End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy for cancer via existing hemodialysis fistulas, and the consequences of central venous access in a fourth patient are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/112972980500600408 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!